All Insights Report Targeted Literature Review Of Economic Burden And Modelling Techniques For Duchenne Muscular Dystrophy

    Targeted Literature Review Of Economic Burden And Modelling Techniques For Duchenne Muscular Dystrophy

    Real-World Evidence

    Targeted Literature Review Of Economic Burden And Modelling Techniques For Duchenne Muscular Dystrophy

    Examine the economic burden of Duchenne Muscular Dystrophy(DMD) and Becker muscular dystrophy(BMD), evaluates current economic evaluation techniques and data sources.

    Download Report
    Targeted Literature Review Of Economic Burden And Modelling Techniques For Duchenne Muscular Dystrophy

    Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare X-linked recessive ailments impacting 1 in 7,250 people in the United States (U.S.). Currently, DMD has no known cure. Disease management is aimed at preserving the quality of life and extending survival. The objective of this study is to assess economic burden, current economic evaluation techniques, and data sources for DMD economic evaluation and identify evidence gaps in DMD burden and provide details on the value of existing DMD treatments.

    Contact us at insights@axtria.com with any questions.

    Complete the brief form to download the white paper

    Recommended insights

    Economic Burden & Modelling Techniques Report

    Article

    Unveiling The Key Trends and Topics: Axtria's Insights from ISPOR US 2024

    Economic Burden & Modelling Techniques Report

    Article

    Modeling the "Difficult to Model" Disease: Considerations for Evaluating the Cost-Effectiveness in Rare Diseases

    Economic Burden & Modelling Techniques Report

    White Paper

    The Use of Natural Language Processing in Literature Reviews